Week 2 - Endocrine Flashcards

1
Q

Actions of Insulin

A

(stimulated by high blood glucose, inhibited by somatostatin) (made by beta cells in pancreas)
Liver: glucose to glycogen
Fat: fatty acid + glycerol to fat
Muscle: amino acids to protein
GLUT4 in muscle and adipose is stimulated by insulin to uptake glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glucagon actions

A
prevents hypoglycemia (made in alpha cells in pancreas) (stim by glucose, insulin, etc, inhibited by amino acids)
Liver: glycogen to glucose, glucose out into blood, amino acids in
Adipose: release free fatty acids (makes ketoacids in the liver)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Glucagon-Like peptides (GLPs)

A

secreted by gut in response to feeding
acute: increases insulin response to glucose
Chronic: increases beta-cell mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis of DM

A

HbA1C more than 6.5 (norm under 5.7)
fasting glucose more than 126 (norm under 100)
2hr glucose post 75g glucose over 200 (norm under 140)
random glucose over 200

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medications for T2DM

A

Insulin- most potent
Sulfonylurea- (glipizide, glyburide, glimepiride) stim insulin release via K-channel
Meglitinide- (repaglinide, nateglinide) stim insulin release via K-channel
Biguanide- (metformin) decrease systemic glucose output - can cause lactic acidosis(don’t use in renal insuff)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnose metabolic syndrome

A
waist circum over 40in or 35in
triglyceride over 150
HDL under 40 or 50
BP over 130/85
fasting glucose over 100
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanisms of insulin resistance

A

Inflammation: cytokines- IL1, TNFa, IL6- JNK- IRS-1- inhibits insulin receptor fxn
Lipid overload: fatty acids- fatty acyl coa- increase DAGS (diacylglycerols)- increase nPKC and serine kinases- IRS-1- inhibit insulin action
Lipotoxicity: deposition of lipids and fat in liver and skeletal muscle, and also in islet beta cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tx of metabolic syndrome

A
Tx obesity: orlistat (inhibits lipases)
Tx HTN: ACE inhibitors or ARBs
Tx LDL: statins or ezetimibe
Tx trigs and HDL: fibrates or niacin
Tx dm: metformin
Tx cardio risk: aspirin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathophys of T1DM in kids

A
environmental trigger (virus)- B-cell antigen (GAD65)- cytokines- CD4- Th1- CD8 CTLs- attack pancreas
start symptoms when 90% beta cells are gone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type 1 DM

A

labs: low Na, low K (but may be high in serum), low bicarb (ketoacidosis), phosphaturia
Biochem: dehydration and hypovolumemia from severe hyperglycemia thus osmotic diuresis,, also from vomiting and metabolic acidosis from ketoacids from starvation mode from lack on intracellular glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Insulin preps

A

short: aspart, lispro, glulisine (monomeric)
Regular
Longish: NPH (forms hexamers)
Long: detemir, glargine (forms microprecipitate)
Sides: hypoglycemia, lipohypertrophy, atherosclerosis, cancer risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Insulin overdose (hypoglycemia)

A

mild: increased sympathetic tone, give oral fast carbs
moderate: neuro sx, give fast carbs sugar-gel
severe: seizure, coma, give glucagon injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hypoglycemia

A

generally less than 70 mg/dl glucose
Whipple’s Triad: sx of hypogly, low measured plasma glucose, resolution of sx with increased glucose
Hormone resopnse: Insulin decreases, glucagon increases (gluconeogenesis in liver), epinephrine increases (b2-adrenergic increases substrate), cortisol and growth hormone increase (limit glucose utilization and increase gluconeogenesis)
Sx: neurogenic (tremor, anxiety, sweating), neuroglycopenic (behavior, psychomotor, visual, seizures, coma)
Causes: insulin/drugs, critical illness, cortisol def, insulinoma, autoimmune insulin
Dx: use 72-hr supervised fast test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Insulinoma

A

hypoglycemia
mostly benign, solitary, small
dx by hormone studies when hypoglycemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

72-hr fast test for hypoglycemia

A
Test for:
glucose (if low then hypoglycemia)
Insulin (if high then insulinoma or drugs or autoimmune)
c-peptide (only in endogenous insulin)
sulfonylurea (if present then drugs)
proinsulin (elevated in insulinoma)
B-hydroxybutyrate (low in insulinoma)
response to IV glucagon (if respond then hyperinsulin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MEN1

A

11q13, autosomal dominant
Parathyroid adenoma
pituitary adenoma
enteropancreatic tumors
DX: 2 or more assoc tumors, one tumor and 1st deg relative with MEN1, has MEN1 mutation
NO genotype/phenotype correlation
-identifying mutation allows for genetic counseling and screening family members

17
Q

MEN2

A
10-10q11.2, autosomal dominant, RET mutations
Medullary thyroid cancer
pheochromocytoma
A: parathyroid hyperplasia
B: mucosal neuromas, marfanoid habitus
-Have typical facies
Genotype predicts severity and risk
18
Q

Sulfonylureas

A

Glipizide, Glyburide, Glimeprimide
for diabetes: stimulates insulin secretion by pancreas by inactivating a K-channel, influx of Ca
Sides: rashes and drug interaction with warfarin, hypoglycemia

19
Q

Biguanide (Metformin)

A

for diabetes (1st line)
sensitizes liver to insulin-> decreased hepatic gluconeogenesis
Sides: GI probs, lactic acidosis
Contra: renal insuff, CHF, hypoxia, liver dysfxn
Also lowers CV and cancer risks

20
Q

Thiazolidinediones

A

Pioglitazone, rosiglitazone
for diabetes
PPAR receptor agonists, make peripheral tissues more sensitive to insulin
Sides: liver tox, weight gain, fluid retention, bladder cancer
Contra: CHF

21
Q

Alpha-Glucosidase inhibitors

A

acarbose
for diabetes, nhibits enteric enzymes that break down complex carbs
reduces post-prandial hyperglycemia
sides: bloating, flatulence

22
Q

GLP-1 analogs

A

exenatide, liraglutide
for diabetes
GLPs are stimulated by eating and augments response to insulin, increase beta cell mass, inhibits glucagon, promotes weight loss

23
Q

DPP-4 inhibitors

A

sitagliptin
for diabetes
DPP-4 degrades GLP-1 so these drugs prolong GLP action

24
Q

SGLT-2 inhibitors

A

Canagliflozin
for diabetes
inhibits Na-glucose transporter in the kidney proximal tubule, thus increases renal glucose loss
Sides: yeast infxn, dehydration